Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of dermatologist Lawrence Green, MD, FAAD to the position of Scientific Advisory Board (SAB) member. In this role, Dr. Green will provide leadership and clinical expertise for dermatology clinical trials and related areas at Biorasi.
Biorasi, a leading global full-service contract research organization (CRO),is proud to announce the appointment of Ole Isacson, MD, PhD, Professor of Neurology and Neuroscience, to the position of Scientific Advisory Board (SAB) member. In this role, Dr. Isacson will provide leadership and clinical expertise for neurology clinical trials and related areas at Biorasi.
As Head of Operations for Biorasi in India, I recently completed my first year in the organization, and I wanted to share my experience. It’s amazing how time flies so quickly.I joined Biorasi because I always wanted to work with an emerging CRO and be a part of their journey to scale new heights. Looking back at the year and how far we have come, it seems like I have been with this organization for years – such has been the support and encouragement on this extraordinary one-year journey.
Biorasi, a leading global full-service contract research organization (CRO), is proud to announce that Wayne Bowden has taken on the new role of Vice President of Partnerships and Strategy. In this new position, Wayne will be responsible for developing and expanding the company’s strategic partnerships with a focus on establishing preferred provider relationships with key accounts and ensuring the company’s growing client base has the support needed to continuously achieve stellar results.
Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of Becky Knockemus to the position of Vice President of Program Development. Beginning October 2020, Becky will be focusing on pipeline development and sales management, as well as developing short and long-term sales strategies to further Biorasi’s healthy growth trajectory.
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Biorasi has met the First Patient, First Visit milestone for a dermatology trial across multiple sites during the COVID-19 pandemic.
Biorasi is proud to announce the appointment of Scott Nenninger to the position of Chief Financial Officer (CFO)
Biorasi has completed subject visits under Part A in a rare disease nephropathy study during the peak of the COVID-19 outbreak.
